Kidney Cancer

>

Latest News

Line illustration of a pair of kidneys with a tumor on the left kidney
Belzutifan May Lengthen Quality-Adjusted Survival in Advanced RCC

July 21st 2025

A quality-adjusted time without symptoms or toxicity analysis identified better outcomes for patients with RCC treated with belzutifan vs everolimus.

Graphic of a kidney with a tumor
KIM-1 Biomarker May Be Prognostic of Response, Outcomes in RCC

July 21st 2025

Graphic of a kidney
Neoantigen Vaccine Shows Promise in Mutated Renal Cell Carcinoma

July 18th 2025

Graphic of kidneys
Allogenic CAR T-Cell Agent Safe, Active in Heavily Pretreated RCC

July 1st 2025

Anatomical graphic of a kidney
AI Tool May Predict Response, Resistance in Advanced RCC

June 10th 2025

Video Interviews

More News